← FDA Drug Approvals (Drugs@FDA)

TRILEPTAL

NDA · New Drug Application · Sponsor: NOVARTIS · Approved 2001-05-25

Drug application

FDA Application #

NDA021285

Application type

New Drug Application

Brand name

TRILEPTAL

Generic name

OXCARBAZEPINE

Active ingredients

OXCARBAZEPINE

Dosage form

SUSPENSION

Route

ORAL

Marketing status

Prescription

Sponsor

NOVARTIS

Manufacturer

Novartis Pharmaceuticals Corporation

First approval

2001-05-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown